Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 9/2006

01-09-2006 | Editorial

Declassifying diabetes

Author: E. A. M. Gale

Published in: Diabetologia | Issue 9/2006

Login to get access

Excerpt

He who first gave names, gave them according to his conception of the things which they signified, and if his conception was erroneous, shall we not be deceived by him?Socrates
…
Literature
1.
2.
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057
3.
WHO Expert Committee on Diabetes Mellitus (1980) Second Report. World Health Organization, Geneva
4.
Himsworth HP (1936) Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet i:127–130CrossRef
5.
Lister J, Nash J, Ledingham U (1951) Constitution and insulin sensitivity in diabetes mellitus. BMJ i:376–379CrossRef
6.
7.
Joslin EP, Root HF, White P, Marble A, Bailey CC (1947) The treatment of diabetes mellitus. Eighth edition. Henry Kimpton, London, pp 144–146
8.
Rutter M (2003) Categories, dimensions, and the mental health of children and adolescents. Ann N Y Acad Sci 1008:11–21PubMedCrossRef
9.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197
10.
Gale EAM (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195–2199PubMedCrossRef
11.
Gale EAM (2005) Spring harvest? Reflections on the rise of type 1 diabetes. Diabetologia 48:2445–2450PubMedCrossRef
12.
Faber K (1923) Nosography in modern internal medicine. Oxford University Press, Oxford
13.
Mayr E (1982) The growth of biological thought. The Belknap Press of Harvard University Press, Cambridge, Massachusetts
14.
UK Prospective Diabetes Study (UKPDS) (1995) 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310:83–88
15.
Davis TME, Wright AD, Mehta ZM et al (2005) Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 48:695–702PubMedCrossRef
16.
Metadata
Title
Declassifying diabetes
Author
E. A. M. Gale
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0348-7

Other articles of this Issue 9/2006

Diabetologia 9/2006 Go to the issue

Article

Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects

Research Letter

Increased syndecan-1 in serum is related to early nephropathy in type 1 diabetes mellitus patients

Article

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Article

The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study

Article

Clinical validation of a link between TNF-α and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy

Article

The UK case–control study of cerebral oedema complicating diabetic ketoacidosis in children
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits